Get started
Author

Mutsumi Fujimoto

Dynamic changes of blood glucose level during capivasertib treatment in metastatic breast cancer: a case report
2025 · Shinsuke Sasada, Haruya Ohno, et al. · Diabetology International · 7
PDF
Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy
2024 · Hideo Shigematsu, Mutsumi Fujimoto, et al. · Journal of Magnetic Resonance Imaging · 4
PDF
Exploring the possibility of omitting axillary surgery in patients with clinical node-positive breast cancer achieving ypT0 after neoadjuvant chemotherapy
2025 · Hideo Shigematsu, Momoko Takaya, et al. · Breast Cancer Research and Treatment · 3
PDF
Differences of HER2 Status by HercepTest and PATHWAY 4B5 Immunohistochemical Assays in Breast Cancer
2026 · SHINSUKE SASADA, MOMOKO TAKAYA, et al. · Anticancer Research · 1
Prognostic value of FDG PET/CT in special types of breast cancer with non-favorable histology
2025 · Mutsumi Fujimoto, Momoko Takaya, et al. · Discover Oncology · 1
PDF
Decisional regret following risk-reducing mastectomy versus surveillance among Japanese women with breast cancer carrying BRCA1/2 pathogenic variants
2026 · Ai Amioka, Marino Teshima, et al. · Research Square
PDF
Abstract PS2-12-26: Tp53-dependent and -independent transcriptomic responses to pan-14-3-3 inhibition under dna damage in breast cancer cells
2026 · E. HIRAOKA, H. SHIGEMATSU, et al. · Clinical Cancer Research
Abstract P2-09-07: Diagnostic performance of TILs-US Score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer
2025 · Hideo Shigematsu, Kayo Fukui, et al. · Clinical Cancer Research
Abstract P5-08-18: Prognostic Value of FDG-PET/CT in Breast Cancer with Unfavorable Special Histology
2025 · Mutsumi Fujimoto, Haruka Ikejiri, et al. · Clinical Cancer Research
Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation
2025 · Hideo Shigematsu, Mutsumi Fujimoto, et al. · World Journal of Surgical Oncology
PDF
Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer
2024 · Hideo Shigematsu, Kayo Fukui, et al. · International Journal of Clinical Oncology
PDF
A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score
2024 · Hideo Shigematsu, Kayo Fukui, et al. · Japanese Journal of Clinical Oncology
PDF
Linking the companion diagnostic function of cancer genome profiling to therapy: Investigation of TMB-high predictors.
2024 · Emiko Hiraoka, Akiko Emi, et al. · Journal of Clinical Oncology
Abstract PO3-07-12: Effect of neoadjuvant chemotherapy on peritumoral edema in early stage breast cancer and its prognostic value
2024 · Hideo Shigematsu, Mutsumi Fujimoto, et al. · Cancer Research
A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
2023 · Mutsumi Fujimoto, Yoshie Kobayashi, et al. · Surgical Case Reports
PDF
Po144 Oral Hygiene Parameters for Febrile Neutropenia During Breast Cancer Chemotherapy
2023 · Mutsumi Fujimoto, Shinsuke Sasada, et al. · The Breast
Abstract P4-09-11: Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
2023 · Yoshie Kobayashi, Yusuke Motoi, et al. · Cancer Research
[A Case of Breast Metastasis from Renal Cell Carcinoma].
2022 · Ayumi Kawamata, Akiko Emi, et al. · PubMed
Works count: 18
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type